Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Publications

Pre-labelling versus direct labelling of anthrax proteins for imaging of matrix metalloproteinases activity using DOTA-GA.

Journal article

Xavier M-AE. et al, (2019), Nucl Med Biol, 72-73, 49 - 54

Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.

Journal article

Tacconi EM. et al, (2019), EMBO Mol Med

PET Imaging of DNA Damage Response following 225Ac-radioimmunotherapy in a Pancreatic Ductal Adenocarcinoma Mouse Model

Conference paper

Poty S. et al, (2019)

Call to arms: need for radiobiology in molecular radionuclide therapy.

Journal article

Terry SYA. et al, (2019), EJNMMI 2019 Editorial. In Press.

Imaging DNA damage response

Conference paper

Cornelissen B., (2019), RADIOTHERAPY AND ONCOLOGY, 133, S291 - S291

Dual-Isotope Imaging Allows In Vivo Immunohistochemistry using Radiolabelled Antibodies in Tumours.

Journal article

KNIGHT JC. et al, (2019), Nuclear Medicine and Biology

Translational molecular imaging in exocrine pancreatic cancer.

Journal article

Cornelissen B. et al, (2018), Eur J Nucl Med Mol Imaging, 45, 2442 - 2455

PET imaging of PARP expression using [18F]olaparib.

Journal article

Wilson T. et al, (2018), J Nucl Med

[18F]Olaparib: Precision Radiolabelling of PARP Inhibitors for In Vivo Imaging

Conference paper

Wilson T. et al, (2018), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, S662 - S662

Early Detection of Pancreatic Cancer in KPC Mice by Imaging DNA Damage Signalling

Conference paper

Knight JC. et al, (2018), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, S192 - S192

Dual-Isotope Imaging Reveals Inter-Individual Differences in Passive Uptake of Radiolabelled Antibodies in Tumours

Conference paper

Knight JC. et al, (2018), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, S109 - S110

Radiolabelled Bacillus anthracis toxin-based probes for molecular imaging of MMP activity in tumour models

Conference paper

Xavier ME. et al, (2018), EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 45, S193 - S194

99mTc-duramycin imaging reveals variable tissue toxicity of cancer drugs

Journal article

SNEDDON D. et al, (2018), Journal of Nuclear Medicine

Tc-99m-duramycin imaging reveals variable tissue toxicity of cancer drugs

Conference paper

Sneddon D. et al, (2018), JOURNAL OF NUCLEAR MEDICINE, 59

Non-invasive PET imaging of radiosensitive tumour regions using gamma H2AX-targeted immunoconjugate

Conference paper

Yaromina A. et al, (2018), RADIOTHERAPY AND ONCOLOGY, 127, S1282 - S1282

Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody.

Journal article

Torres JB. et al, (2018), Mol Imaging Biol, 20, 292 - 299

Monitoring response to anti-angiogenic mTOR inhibitor therapy in vivo using 111In-bevacizumab.

Journal article

Patel N. et al, (2017), EJNMMI Res, 7

89Zr-anti-γH2AX-TAT but not 18F-FDG Allows Early Monitoring of Response to Chemotherapy in a Mouse Model of Pancreatic Ductal Adenocarcinoma.

Journal article

Knight JC. et al, (2017), Clin Cancer Res, 23, 6498 - 6504

In Vivo Pretargeted Imaging of HER2 and TAG-72 Expression Using the HaloTag Enzyme.

Conference paper

Knight JC. et al, (2017), Mol Pharm, 14, 2307 - 2313

Imaging the DNA damage response with PET and SPECT.

Journal article

Knight JC. et al, (2017), Eur J Nucl Med Mol Imaging, 44, 1065 - 1078

Load More